Therefore, a long multi-epitope peptide vaccine was designed using two common TAA antigen peptides in GBM (BIRC5 and EphA2), and the universal PADRE with the purpose of stimulating CD4+ and CD8+ T cells was investigated in this study. Here, BIRC5 is linked to glioblastoma.